Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_assertion type Assertion NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_head.
- NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_assertion description "[Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_provenance.
- NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_assertion evidence source_evidence_literature NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_provenance.
- NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_assertion SIO_000772 23396606 NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_provenance.
- NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_assertion wasDerivedFrom befree-20140225 NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_provenance.
- NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_assertion wasGeneratedBy ECO_0000203 NP253592.RAtC36fr39-WUDwubQ-t52nFyJLYlEErZ1hfYx2Xh69Y4130_provenance.